QAM
WST icon

Q3 Asset Management’s West Pharmaceutical WST Stock Holding History

Q3 Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-676
Closed -$254K – 71
2023
Q3 		$254K Sell
676
-709
-51% -$274K 0.1% 40
2023
Q2 		$530K Buy
+1,385
New +$495K 0.26% 37
2021
Q4 		– Sell
-1,956
Closed -$830K – 67
2021
Q3 		$830K Buy
+1,956
New +$825K 0.4% 27

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Q3 Asset Management's WST Position: Q4 2023 in Review

Q3 Asset Management sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 676 shares — an estimated $254K sold.

Q3 Asset Management first reported a position in WST in Q3 2021 and held it in 3 quarters. The position peaked at $830K in Q3 2021. 782 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Q3 Asset Management reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Q3 Asset Management sold 676 West Pharmaceutical shares in Q4 2023, an estimated $254K.
  • Q3 Asset Management first reported a position in West Pharmaceutical in Q3 2021 and held it in 3 quarters.
  • Q3 Asset Management's West Pharmaceutical position peaked at $830K in Q3 2021.
  • 782 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Q3 Asset Management's 13F filing for Q4 2023, filed 29 Jan 2024.